89901-03-1

Basic information

• Product Name: METHYL 4'-BROMO[1,1'-BIPHENYL]-4-CARBOXYLATE
• Synonyms: AKOS BAR-2392;METHYL 4'-BROMO[1,1'-BIPHENYL]-4-CARBOXYLATE;Methyl 4'-bromobiphenyl-4-carboxylate, 95%;Methyl 4-(4-bromophenyl)benzoate, 4'-Bromo-4-(methoxycarbonyl)biphenyl;4′-Bromobiphenyl-4-carboxylic acid methyl ester;Methyl 4-(4-bromophenyl)benzoate;[1,1'-Biphenyl]-4-carboxylicacid, 4'-bromo-, methyl ester
• CAS NO: 89901-03-1
• Molecular Formula: C₁₄H₁₁BrO₂
• Molecular Weight: 291.14
• Mol File: 89901-03-1.mol
• Article Data: 17

Chemical Properties

• Melting Point: 146-148°C
• Boiling Point: 382.7 °C at 760 mmHg
• Flash Point: 185.3 °C
• Appearance: /
• Density: 1.394 g/cm³
• Water Solubility: Slightly soluble in water.
• CAS DataBase Reference: METHYL 4'-BROMO[1,1'-BIPHENYL]-4-CARBOXYLATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 4'-BROMO[1,1'-BIPHENYL]-4-CARBOXYLATE(89901-03-1)
• EPA Substance Registry System: METHYL 4'-BROMO[1,1'-BIPHENYL]-4-CARBOXYLATE(89901-03-1)

Safety Data

• Hazard Codes: Xi,N
• Statements: 36/37/38-50/53-41
• Safety Statements: 26-36/37/39-61-60-39
• RIDADR: UN 3077 9 / PGIII
• WGK Germany: 2
• HazardClass: IRRITANT
• Hazardous Substances Data: 89901-03-1(Hazardous Substances Data)

Usage

Uses

It is employed in the design, synthesis, and biological evaluation of novel nonsteroidal farnesoid x receptor (fxr) antagonists.

Upstream product

• 67-56-1 methanol 
• 5731-11-3 4-(4-bromophenyl)benzoic acid 
• 50670-58-1 4-formyl-4'-bromobiphenyl 
• 92-86-4 4-(4-bromophenyl)bromobenzene 
• 619-44-3 methyl 4-iodobenzoate 
• 5467-74-3 4-Bromophenylboronic acid 
• 619-42-1 4-methoxycarbonylphenyl bromide 
• 67132-16-5 4-bromobiphenyl-4'-carbonyl chloride 
• 589-87-7 1,4-bromoiodobenzene 
• 99768-12-4 4-methoxycarbonylphenylboronic acid 
• 106-40-1 4-bromo-aniline 
• 1878-68-8 2-(4-bromophenyl)-acetic acid 
• 1363789-11-0 4-bromobenzenediazonium bis((trifluoromethyl)sulfonyl)amide 

Downstream Products

• 84337-86-0 <4-(4-bromophenyl)phenyl>methanol 
• 1018967-64-0 4-(4'-methoxylcarbonylphenyl)-4''-(4'''-(3'''',7''''-dimethyloctanyl)phenyl)-diphenylacetylene 
• 1595145-35-9 (S)-methyl 4'-(6-(2-((4-cyanophenylethyl)carbamoyl)azetidin-1-yl)-2-(trifluoromethyl)pyrimidin-4-yl)-[1,1'-biphenyl]-4-carboxylate 
• 1595145-37-1 4-(4-{6-[(2S)-2-{[2-(4-cyanophenyl)ethyl]carbamoyl}azetidin-1-yl]-2-(trifluoromethyl)pyrimidin-4-yl}phenyl)benzoic acid 
• 1381957-27-2 methyl 4’-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,1’-biphenyl-4-carboxylate 
• 50670-57-0 4-bromo-4'-(bromomethyl)-1,1'-biphenyl 

Relevant articles and documents

The Development of Benzimidazole-Based Clickable Probes for the Efficient Labeling of Cellular Protein Arginine Deiminases (PADs)

Citrullination is the post-translational hydrolysis of peptidyl-arginines to form peptidyl-citrulline, a reaction that is catalyzed by the protein arginine deiminases (PADs), a family of calcium-regulated enzymes. Aberrantly increased protein citrullinati

Dihydropyrimidine compound and uses of dihydropyrimidine compound in drugs

The present invention relates to a dihydropyrimidine compound and uses of the dihydropyrimidine compound as drugs, particularly as drugs for treatment and prevention of hepatitis B, particularly to acompound represented by a general formula (I) or (Ia) or an enantiomer, a diastereomer, a tautomer, a hydrate, a solvate or a pharmaceutically acceptable salt thereof, wherein each variable is definedin the specification. The invention further relates to uses of the compound represented by a general formula (I) or (Ia) or the enantiomer, the diastereomer, the tautomer, the hydrate, the solvate orthe pharmaceutically acceptable salt thereof as drugs, especially as drugs for treatment and prevention of hepatitis B. The formulas (I) and (Ia) are defined in the specification.

GOLD-CATALYZED C-C CROSS-COUPLING OF BORON- AND SILICON-CONTAINING ARYL COMPOUNDS AND ARYLDIAZONIUM COMPOUNDS BY VISIBLE-LIGHT

The present invention relates to a method for producing (functionalized) biaryls by employing a visible-light-driven, gold-catalyzed C-C cross-coupling reaction system involving boron- and silicon-containing aryl compounds and aryldiazonium compounds. Moreover, the present invention relates to the use of such boron- and silicon-containing aryl compounds and aryldiazonium compounds, as well as related gold catalysts, in the manufacture of (functionalized) biaryls.